论文部分内容阅读
新生儿高胆红素血症的治疗,现在已逐渐进入不用交换输血就能预防核黄疸发生的地步。本文报告一种新的方法,口服或静注D-青霉胺(D-Penicillamin),对高胆红素血症有预防及治疗的效果。作者在1973年3一9月,随机抽样119例高胆红素血症的新生儿,出生体重58例为超过2,500克的足月儿,ez例为900~2,500克的早产儿。都采用本药治疗。不论其病因,高胆红素血症的程度及出生体重如何,根据婴儿出生当日及第1天后、第2天后、第3
The treatment of neonatal hyperbilirubinemia has now gradually entered the point of preventing the occurrence of kernicterus without exchange of blood transfusions. This article reports a new method of oral or intravenous D-penicillamin (D-Penicillamin) for the prevention and treatment of hyperbilirubinemia. The authors randomized 119 newborns with hyperbilirubinemia between March and September 1973 with 582 births of full-term infants of more than 2,500 grams and 900 to 2,500 grams of preterm infants. Have adopted the drug treatment. Regardless of etiology, degree of hyperbilirubinemia and birth weight, according to the day of birth and after the first day of the baby, after the first two days, the third day